ABSTRACT
An investigation into the methanol extracts obtained from the stems of Dodonaea viscosa led to the isolation of one nor-clerodane diterpene (1) and two labdane diterpenes (2, 3), as well as 17 known compounds (4-20). The structures of these compounds were elucidated based on chemical and spectral evidence. The stereochemical structure of the nor-clerodane diterpene was confirmed via its circular dichroism spectrum and calculated electronic circular dichroism spectrum. Isolated compounds were evaluated for their inhibitory effects on collagenase and tyrosinase. Since 5,7,4'-trihydroxy-3'-(4-hydroxy-3-methylbutyl)-5'-(3-methylbut-2-enyl)-3,6-dimethoxyflavone (9) showed collagenase inhibitory activity and scopoletin (12) had significant tyrosinase inhibitory activity, they were considered to be good candidates for cosmetic agents.
Subject(s)
Diterpenes/isolation & purification , Plant Extracts/isolation & purification , Sapindaceae/chemistry , Agaricales/enzymology , Diterpenes/chemistry , Diterpenes/pharmacology , Gelatinases/antagonists & inhibitors , Gelatinases/metabolism , Molecular Structure , Monophenol Monooxygenase/antagonists & inhibitors , Monophenol Monooxygenase/metabolism , Plant Extracts/chemistry , Plant Extracts/pharmacology , StereoisomerismABSTRACT
Fibroblast growth factor (FGF) 21 is a class of hepatokines that plays a protective role against obesity, insulin resistance, and liver damage. Despite this, protective effects of FGF21 in human appear to be minimal, possibly due to its proteolytic cleavage by the fibroblast activation protein (FAP). Here, we presented a novel FAP inhibitor, BR103354, and described its pharmacological activities as a potential therapeutic agent for the treatment of metabolic disorders. BR103354 inhibited FAP with an IC50 value of 14 nM, showing high selectivity against dipeptidyl peptidase (DPP)-related enzymes and prolyl oligopeptidase (PREP). In differentiated 3T3/L1 adipocytes, the addition of FAP diminished hFGF21-induced Glut1 and phosphorylated levels of ERK, which were restored by BR103354. BR103354 exhibited good pharmacokinetic properties as evidenced by oral bioavailability of 48.4% and minimal hERG inhibition. Single co-administration of BR103354 with hFGF21 reduced nonfasting blood glucose concentrations, in association with increased intact form of hFGF21 in ob/ob mice. Additionally, chronic treatment of BR103354 for 4 weeks reduced nonfasting blood glucose concentrations with improved glucose tolerance and with reduced triglyceride (TG) content in liver of ob/ob mice. Consistently, BR103354 improved hepatic steatosis and fibrosis in a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD)-induced non-alcoholic steatohepatitis (NASH) mouse model. FAP inhibitory effects of BR103354 were confirmed in normal cynomolgus monkeys. Together, BR103354 acts as an effective FAP inhibitor in vitro and in vivo, thereby demonstrating its potential application as an anti-diabetic and anti-NASH agent.
Subject(s)
Fatty Liver/drug therapy , Gelatinases/antagonists & inhibitors , Glucose Metabolism Disorders/drug therapy , Hypoglycemic Agents/pharmacology , Membrane Proteins/antagonists & inhibitors , 3T3-L1 Cells , Adipocytes/drug effects , Animals , Drug Discovery , Drug Evaluation, Preclinical , Endopeptidases , Macaca fascicularis , Male , Mice , Mice, Inbred C57BL , Rats, Sprague-Dawley , Serine EndopeptidasesABSTRACT
BACKGROUND: Aloe's reported bioactivities (anticancer, anti-inflammatory and wound healing) suggest they might inhibit a subgroup of matrix metalloproteinases (MMPs) called gelatinases (MMP-2 and MMP-9). The goal of the present study was to compare the MMP inhibitory potential of two Aloe species, A. vera and A. arborescens. METHODS: Different types of extraction were tested and specific bioactive compounds were quantified. Cancer cell invasion inhibitory activities were measured in vitro using the wound healing assay in human colon cancer cells (HT29). Effects on gelatinase activities were further assessed by dye-quenched gelatin and gelatin zymography. RESULTS: Different types of extraction yielded significantly different levels of bioactivities and of bioactive compounds, which might be due to a greater amount of extractable bioactive compounds such as anthraquinones. Both A. arborescens and A. vera have potential as inhibitory agents in cancer cell proliferation via MMP-9 and MMP-2 enzymatic activity inhibition, being able to reduce colon cancer cell proliferation and migration but A. arborescens showed to be a more effective inhibitor of cancer cell migration than A. vera. CONCLUSION: This work opens novel perspectives on the mode of action of Aloe species in cancer cell migration and may provide clues as to why there are so many conflicting results on Aloe's activities.
Subject(s)
Adenocarcinoma/drug therapy , Aloe , Colonic Neoplasms/drug therapy , Gelatinases/antagonists & inhibitors , Plant Extracts/therapeutic use , Cell Movement/drug effects , Drug Screening Assays, Antitumor , HT29 Cells , Humans , Plant Extracts/pharmacology , Species SpecificityABSTRACT
Cancer-associated fibroblasts (CAFs) are strongly implicated in tumor progression, including in the processes of tumorigenesis, invasion, and metastasis. The targeting of CAFs using various therapeutic approaches is a novel treatment strategy; however, the efficacy of such therapies remains limited. Recently, near-infrared photoimmunotherapy (NIR-PIT), which is a novel targeted therapy employing a cell-specific mAb conjugated to a photosensitizer, has been introduced as a new type of phototherapy. In this study, we have developed a novel NIR-PIT technique to target CAFs, by focusing on fibroblast activation protein (FAP), and we evaluate the treatment efficacy in vitro and in vivo. Esophageal carcinoma cells exhibited enhanced activation of fibroblasts, with FAP over-expressed in the cytoplasm and on the cell surface. FAP-IR700-mediated PIT showed induced rapid cell death specifically for those cells in vitro and in vivo, without adverse effects. This novel therapy for CAFs, designed as local control phototherapy, was safe and showed a promising inhibitory effect on FAP+ CAFs. PIT targeting CAFs via the specific marker FAP may be a therapeutic option for CAFs in the tumor microenvironment in the future.
Subject(s)
Cancer-Associated Fibroblasts/metabolism , Esophageal Squamous Cell Carcinoma/metabolism , Esophageal Squamous Cell Carcinoma/pathology , Gelatinases/antagonists & inhibitors , Gelatinases/metabolism , Membrane Proteins/antagonists & inhibitors , Membrane Proteins/metabolism , Serine Endopeptidases/metabolism , Animals , Cancer-Associated Fibroblasts/pathology , Cell Line, Tumor , Cell Survival/drug effects , Disease Progression , Endopeptidases , Esophageal Squamous Cell Carcinoma/therapy , Humans , Immunotherapy , Mice , Photosensitizing Agents/pharmacology , Phototherapy , Tumor Microenvironment/drug effects , Tumor Microenvironment/immunology , Xenograft Model Antitumor AssaysABSTRACT
Membrane type-1 matrix metalloproteinase (MT1-MMP) is a transmembrane MMP which triggers intracellular signaling and regulates extracellular matrix proteolysis, two functions that are critical for tumor-associated angiogenesis and inflammation. While green tea catechins, particularly epigallocatechin gallate (EGCG), are considered very effective in preventing MT1-MMP-mediated functions, lack of structure-function studies and evidence regarding their direct interaction with MT1-MMP-mediated biological activities remain. Here, we assessed the impact in both cellular and biophysical assays of four ungallated catechins along with their gallated counterparts on MT1-MMP-mediated functions and molecular binding partners. Concanavalin-A (ConA) was used to trigger MT1-MMP-mediated proMMP-2 activation, expression of MT1-MMP and of endoplasmic reticulum stress biomarker GRP78 in U87 glioblastoma cells. We found that ConA-mediated MT1-MMP induction was inhibited by EGCG and catechin gallate (CG), that GRP78 induction was inhibited by EGCG, CG, and gallocatechin gallate (GCG), whereas proMMP-2 activation was inhibited by EGCG and GCG. Surface plasmon resonance was used to assess direct interaction between catechins and MT1-MMP interactors. We found that gallated catechins interacted better than their ungallated analogs with MT1-MMP as well as with MT1-MMP binding partners MMP-2, TIMP-2, MTCBP-1 and LRP1-clusterIV. Overall, current structure-function evidence supports a role for the galloyl moiety in both direct and indirect interactions of green tea catechins with MT1-MMP-mediated oncogenic processes.
Subject(s)
Catechin/analogs & derivatives , Matrix Metalloproteinase 14/metabolism , Tea/chemistry , Carcinogenesis/drug effects , Catechin/metabolism , Catechin/pharmacology , Cell Line, Tumor , Concanavalin A/pharmacology , Endoplasmic Reticulum Chaperone BiP , Enzyme Precursors/antagonists & inhibitors , Gelatinases/antagonists & inhibitors , Glioblastoma/pathology , Heat-Shock Proteins/antagonists & inhibitors , Humans , Matrix Metalloproteinase 14/pharmacology , Matrix Metalloproteinase Inhibitors/pharmacology , Protein Binding , Structure-Activity RelationshipABSTRACT
Exposure to UV radiation to human skin up-regulates the synthesis of matrix metalloproteinase (MMP) family. Gelatinases are member of MMPs which have been suggested to play an important role in photoaging such as wrinkle formation. To inhibit gelatinase activity is regarded to be very important to keep healthy skin and to protect wrinkle formation. On the other hand, anti-photoaging agents are expected to be derived from natural resources, especially plants. Plant extracts having gelatinase-inhibitory effect that might be used as safe anti-photoaging ingredient were widely screened. An extract of rhizomes of Curcuma longa L. showed inhibitory effect of gelatinase activity. Curcuminoids and slight amount of compound, 6,11-dihydroxy-3-(4-hydroxy-3-mthoxyphenethyl)-7-[(E)-4-(4-hydroxy-3-methoxyphenyl)-2-oxo-3-butenyl]-10-methoxy-2-oxabicyclo[6.3.1.]dodeca-1(11),8(12),9-trien-5-yl (E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate (curcuminoid D) were isolated as the gelatinase-inhibitory components from methanol extract of rhizomes. The structure of curcuminoid D was determined by means of spectral data including 1H- and 13C-NMR, and IR. Curcumin exerted the enhancing effect on deposition of basement membrane component at dermal-epidermal junction in skin equivalent model. Topical application of cream containing turmeric extract significantly improved facial skin elasticity and decreased the number of gelatinase-positive stratum corneum clusters in human facial skins. These results indicated that turmeric is an effective ingredient to improve skin condition and to prevent skin from photoaging by suppressing activation of gelatinase chronically caused by UV.
Subject(s)
Curcuma/chemistry , Gelatinases/antagonists & inhibitors , Plant Extracts/pharmacology , Rhizome/chemistry , Skin/drug effects , Cells, Cultured , Curcumin/pharmacology , Humans , Infant, Newborn , Keratinocytes/drug effects , Keratinocytes/physiology , Male , Methanol/pharmacology , Protective Agents/pharmacology , Skin/radiation effects , Skin Physiological Phenomena/drug effects , Ultraviolet Rays/adverse effectsABSTRACT
Diabetic retinopathy (DR) is the most common cause of vision loss in patients with diabetes mellitus. Despite the presence of effective therapy, DR is still a significant health burden. A recent research suggests that matrix metalloproteinases (MMPs) could be promising targets, which exert multiple actions on early- and late-stage pathogenesis of DR. Among the MMP family, gelatinases (MMP-2 and MMP-9) act as potent proinflammatory, proangiogenic, and pro-apoptotic factors. Therefore, the pharmacological inhibitory effect of gelatinases on retinal MMP-producing cells may be useful in the treatment or prevention of DR. Nobiletin isolated from citrus plants is a multi-functional polymethoxylated flavone, which exerts biological effects including inhibitory action against MMP activity in several cancer cells. In the present study, we demonstrated that nobiletin isolated from citrus plants attenuated MMP-9 enzymatic activity through the suppression of transcription for MMP-9 gene expression and augmentation of TIMP-1 production in retinal Müller cells. Nobiletin regulated MMP-9 gene expression and TIMP-1 by inhibiting the PI3K/Akt signaling pathway. In addition, we observed the augmentation of inhibitory action against MMP-9 enzymatic activity by 4'-demethylated nobiletin, which is a major metabolite of nobiletin. We believe that the enhancement of inhibitory action against MMP-9 enzymatic activity by 4'-demethylated nobiletin is through the dual inhibition on Erk1/2 and Akt phosphorylation. The structure-activity relationship analysis revealed that, for the enhancement of inhibitory action against MMP-9 enzymatic activity, demethylation at position 4' in B-ring was a key structural modification in Müller cells, which are an important source of MMPs found in vitreous fluid and retinal tissues in retinal proliferative diseases. These results suggested that nobiletin, derived from a natural source, may serve as a novel MMP inhibitor with minimal side effects, and lead compound for the design of more efficacious drugs.
Subject(s)
Citrus/chemistry , Ependymoglial Cells/drug effects , Flavones/pharmacology , Gelatinases/antagonists & inhibitors , Plant Extracts/pharmacology , Cell Line , Ependymoglial Cells/metabolism , Flavonoids/pharmacology , Humans , MAP Kinase Signaling System/drug effects , Matrix Metalloproteinase 9/metabolism , Mitogen-Activated Protein Kinases/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation/drug effects , Signal Transduction/drug effects , Structure-Activity RelationshipABSTRACT
Matrix metalloproteinases (MMPs) play a crucial role in developing different types of lung diseases, e.g., pulmonary arterial hypertension (PAH). Green tea polyphenolic catechins such as EGCG and ECG have been shown to ameliorate various types of diseases including PAH. Our present study revealed that among the four green tea catechins (EGCG, ECG, EC, and EGC), EGCG and ECG inhibit pro-/active MMP-2 activities in pulmonary artery smooth muscle cell (PASMC) culture supernatant. Based on the above, we investigated the interactions of pro-/active MMP-2 with the green tea catechins by computational methods. In silico analysis revealed a strong interaction of pro-/active MMP-2 with EGCG/ECG, and galloyl group has been observed to be responsible for this interaction. The in silico analysis corroborated our experimental observation that EGCG and ECG are active in preventing both the proMMP-2 and MMP-2 activities. Importantly, these two catechins appeared to be better inhibitors for proMMP-2 in comparison to MMP-2 as revealed by gelatin zymogram and also by molecular docking studies. In many type of cells, activation of proMMP-2 occurs via an increase in the level of MT1-MMP (MMP-14). We, therefore, determined the interactions of MT1-MMP with the green tea catechins by molecular docking analysis. The study revealed a strong interaction of MT1-MMP with EGCG/ECG, and galloyl group has been observed to be responsible for the interaction.
Subject(s)
Catechin , Enzyme Precursors , Gelatinases , Matrix Metalloproteinase 2 , Molecular Docking Simulation , Protease Inhibitors , Tea/chemistry , Animals , Catechin/chemistry , Catechin/pharmacology , Cattle , Enzyme Precursors/antagonists & inhibitors , Enzyme Precursors/chemistry , Enzyme Precursors/metabolism , Gelatinases/antagonists & inhibitors , Gelatinases/chemistry , Gelatinases/metabolism , Humans , Matrix Metalloproteinase 2/chemistry , Matrix Metalloproteinase 2/metabolism , Muscle, Smooth, Vascular/enzymology , Myocytes, Smooth Muscle/enzymology , Protease Inhibitors/chemistry , Protease Inhibitors/pharmacologyABSTRACT
Research towards the non-invasive imaging of atherosclerotic plaques is of high clinical priority as early recognition of vulnerable plaques may reduce the incidence of cardiovascular events. The fibroblast activation protein alpha (FAP) was recently proposed as inflammation-induced protease involved in the process of plaque vulnerability. In this study, FAP mRNA and protein levels were investigated by quantitative polymerase chain reaction and immunohistochemistry, respectively, in human endarterectomized carotid plaques. A published boronic-acid based FAP inhibitor, MIP-1232, was synthetized and radiolabeled with iodine-125. The potential of this radiotracer to image plaques was evaluated by in vitro autoradiography with human carotid plaques. Specificity was assessed with a xenograft with high and one with low FAP level, grown in mice. Target expression analyses revealed a moderately higher protein level in atherosclerotic plaques than normal arteries correlating with plaque vulnerability. No difference in expression was determined on mRNA level. The radiotracer was successfully produced and accumulated strongly in the FAP-positive SK-Mel-187 melanoma xenograft in vitro while accumulation was negligible in an NCI-H69 xenograft with low FAP levels. Binding of the tracer to endarterectomized tissue was similar in plaques and normal arteries, hampering its use for atherosclerosis imaging.
Subject(s)
Benzamides , Boron Compounds , Carotid Artery Diseases/diagnostic imaging , Plaque, Atherosclerotic/diagnostic imaging , Radiopharmaceuticals , Actins/genetics , Actins/metabolism , Aged , Animals , Benzamides/pharmacokinetics , Boron Compounds/pharmacokinetics , Carotid Artery Diseases/metabolism , Drug Evaluation, Preclinical , Endopeptidases , Female , Gelatinases/antagonists & inhibitors , Gelatinases/genetics , Gelatinases/metabolism , Gene Expression , Humans , Iodine Radioisotopes , Male , Melanoma, Experimental/diagnostic imaging , Membrane Proteins/antagonists & inhibitors , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Neoplasm Transplantation , Plaque, Atherosclerotic/metabolism , Radionuclide Imaging , Radiopharmaceuticals/pharmacokinetics , Serine Endopeptidases/genetics , Serine Endopeptidases/metabolismABSTRACT
Investigation of collagenase and gelatinase inhibitory natural components afforded two isoflavonoids. Two isoflavonoids, tectorigenin-7-O-ß-D-glucoside (1) and luteolin-7-O-ß-D-glucuronopyranoside (2), were isolated from ethyl acetate fraction of Viola patrinii fermentation extracts (VPFE). Of these, compounds 1 and 2 exhibited collagenase inhibitory activity (IC(50)) at a concentration of less than 1.5 µM, and compound 2 showed gelatinases A and B inhibitory activity (IC(50)) at 0.3 µM and 0.8 µM, respectively.
Subject(s)
Fermentation , Gelatinases/antagonists & inhibitors , Matrix Metalloproteinase Inhibitors , Plant Extracts/chemistry , Protease Inhibitors/chemistry , Protease Inhibitors/isolation & purification , Viola/microbiology , Biocatalysis/drug effects , Chromatography/methods , Collagenases/metabolism , Flavonoids/chemistry , Flavonoids/isolation & purification , Flavonoids/pharmacology , Gelatinases/metabolism , Inhibitory Concentration 50 , Isoflavones/chemistry , Isoflavones/isolation & purification , Isoflavones/pharmacology , Luteolin/chemistry , Luteolin/isolation & purification , Luteolin/pharmacology , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Molecular Structure , Protease Inhibitors/pharmacology , Viola/metabolismABSTRACT
Four oligomeric procyanidins were isolated from the MeOH extracts of the leaves of Crataegus pinnatifida (Rosaceae). Investigation of collagenase and gelatinase inhibitory natural components afforded four oligomeric procyanidins. Of these, 2 and 3 exhibited collagenase inhibitory activity (IC(50)) at a concentration of less than 1 microM, and 3 showed gelatinases A and B inhibitory activity (IC(50)) at 0.4 and 2.3 microM, respectively.
Subject(s)
Crataegus , Gelatinases/antagonists & inhibitors , Matrix Metalloproteinase Inhibitors , Plant Extracts/chemistry , Plant Extracts/pharmacology , Collagenases/metabolism , Gelatinases/metabolism , Humans , Plant Extracts/isolation & purification , Plant LeavesABSTRACT
Great inroads have been made in defining the oncogenic pathways intrinsic to neoplastic cells and the mechanisms by which they are activated in tumors. Knowledge of these pathways provides numerous opportunities that are actively being pursued to develop targeted therapies for cancer. Complementary studies, focused on the non-transformed components of the tumor microenvironment (TME), have revealed that the extrinsic cues provided by the TME are also essential for tumor cells to manifest a fully transformed phenotype, angiogenesis and metastasis. Delineation of these cues and their underlying cellular and molecular pathways will thus lead to a new era of integrative cancer therapy based on combinatorial drug regimens that act synergistically to destroy the neoplastic cells by targeting both the intrinsic and extrinsic pro-oncogenic pathways. Tumor-associated fibroblasts (TAFs) and proteases are two of the key regulators of epithelial-derived tumors that represent potential targets of such integrative therapies. Herein, we consider the potential therapeutic benefit of inhibiting the function of fibroblast activation protein (FAP), a cell surface serine protease with dipeptidyl peptidase and endopeptidase activity that is expressed on TAFs and pericytes, in an integrative approach to treating cancer.
Subject(s)
Antigens, Neoplasm/metabolism , Biomarkers, Tumor/antagonists & inhibitors , Drug Delivery Systems/methods , Fibroblasts/enzymology , Gelatinases/antagonists & inhibitors , Membrane Proteins/antagonists & inhibitors , Neoplasms/enzymology , Neoplasms/therapy , Serine Proteinase Inhibitors/therapeutic use , Animals , Combined Modality Therapy/methods , Combined Modality Therapy/trends , Drug Delivery Systems/trends , Endopeptidases , Fibroblasts/drug effects , Fibroblasts/pathology , Gelatinases/metabolism , Humans , Membrane Proteins/metabolism , Neoplasms/pathology , Serine Endopeptidases/metabolismABSTRACT
Liposarcoma, a malignancy of fat cells, is the most common soft tissue sarcoma. Though rare, poorly differentiated liposarcomas commonly metastasize to lungs and liver, leading to poor prognosis. Prevention of Extracellular matrix (ECM) degradation by inhibition of matrix metalloproteinases (MMPs) activity has been shown to be a promising therapeutic approach to inhibition of cancer progression. A nutrient mixture (NM) containing lysine, proline, ascorbic acid, and green tea extract has shown significant anticancer activity against a number of cancer cell lines. We investigated the effect of NM on liposarcoma cell line SW-872 proliferation (MTT assay), MMP secretion (gelatinase zymography), invasion through Matrigel, and apoptosis and morphology (live green caspase kit and H&E). Liposarcoma cell growth was inhibited by 36 and 61% at 500 and 1,000 microg/ml NM. Zymography demonstrated both MMP-2 and MMP-9 secretion, with PMA-enhanced MMP-9 activity. NM inhibited both MMPs with virtual total inhibition at 500 microg/ml NM. Invasion through Matrigel was inhibited at 100, 500, and 1,000 microg/ml by 44, 75, and 100%, respectively. Dose-dependent apoptosis of liposarcoma cells was evident with NM challenge, with virtually all cells exposed to 1,000 microg/ml NM in late apoptosis. H&E staining did not demonstrate any changes in morphology at lower concentrations. However, some apoptotic changes were evident at higher concentrations. In conclusion, NM significantly inhibited liposarcoma cell growth, MMP activity, and invasion and induced apoptosis in vitro-important parameters for cancer development, suggesting NM as a potential treatment strategy for liposarcoma.
Subject(s)
Antineoplastic Agents/pharmacology , Ascorbic Acid/pharmacology , Camellia sinensis , Gelatinases/antagonists & inhibitors , Liposarcoma/enzymology , Lysine/pharmacology , Apoptosis , Cell Line, Tumor , Cell Proliferation , Drug Combinations , Humans , Matrix Metalloproteinase Inhibitors , Neoplasm Invasiveness , Plant Extracts/pharmacologyABSTRACT
Many proteinases, including gelatinase B/MMP-9, fulfill crucial regulatory or effector functions in disease states and may be pharmacologically targeted by specific inhibitors. Denatured collagen type II provides one of the best gelatinase B substrates, and the characteristics of its cleavage were employed to define the requirements of a novel optimal substrate probe. A synthetic fluorescent derivative was used for the development of a new high-throughput technology for the selection of inhibitors on the principles of sensitivity of confocal fluorescence detection, resolution capacity of capillary electrophoresis, and multichannel power of DNA sequencers. Combinatorial chemical synthesis of a library of peptide-based inhibitors, library deconvolution, high-throughput screening, isolation, and mass spectrometric techniques enabled us to identify a novel single-peptide gelatinase B inhibitor. A notable finding is that the in vitro-selected inhibitor mimics many of the characteristics of the evolution-selected MMP propeptide sequence.
Subject(s)
Combinatorial Chemistry Techniques/methods , Protease Inhibitors/pharmacology , Sequence Analysis, DNA/methods , Binding Sites , Drug Evaluation, Preclinical/methods , Electrophoresis, Capillary/methods , Evolution, Molecular , Gelatinases/antagonists & inhibitors , Gelatinases/metabolism , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinase Inhibitors , Microscopy, Confocal/methods , Molecular Mimicry , Peptide Library , Reproducibility of Results , Sequence Analysis, DNA/instrumentationABSTRACT
The objective of this paper is to assess the gelatinase production by some ocular pathogenic bacterial strains, and evaluate the ability of (-)epigallocatechin-3-gallate (EGCg) to inhibit this gelatinase activity and thus limit bacterial invasion. The effect of EGCg on bacterial gelatinase activity was tested by classic zymography methods, while its effect on bacterial invasion was evaluated through the ability of growing bacteria to liquefy and thus penetrate a semisolid gelatine substrate. It was found that EGCg inhibits bacterial gelatinases with an IC(50) of about 0.2 mM, and limits invasion of gelatinase-positive bacteria at concentrations above 2 mM. These results show for the first time that EGCg, as well as having direct antibacterial activity, can also inhibit bacterial gelatinases, thus limiting their invasion on gelatine. Possible use of EGCg is thus suggested as an adjuvant in antibacterial chemotherapy.
Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Catechin/analogs & derivatives , Catechin/pharmacology , Eye Infections, Bacterial/microbiology , Gelatinases/antagonists & inhibitors , Bacteria/enzymology , Bacteria/isolation & purification , Bacteria/pathogenicity , Culture Media/analysis , Electrophoresis, Polyacrylamide Gel , Eye Infections, Bacterial/drug therapy , Gelatin , Gelatinases/analysis , Gelatinases/biosynthesis , Humans , Microbial Sensitivity Tests , TeaABSTRACT
We have investigated the inhibitory effects of polyphenols from natural products, such as green tea, bilberry, grape, ginkgo, and apple, on rainbow trout gelatinase activities. Gelatinases from the skin, muscle, and blood of rainbow trout contained serine proteinase, metalloproteinase, and other proteinase activities as measured by gelatin zymography. The polyphenols of green tea caused the strong inhibition of some gelatinase activities when compared with those of the other products. This inhibition was quite similar to that of metalloproteinase by ethylenediaminetetraacetic acid, suggesting that the effects of green tea polyphenols on proteinase activities are specific for metalloproteinases. The major catechins of green tea polyphenols were then separated and identified by reverse-phase chromatography to be (-)-epigallocatechin gallate (EGCG), (-)-epigallocatechin, (-)-epicatechin gallate, and (-)-epicatechin. The effects of these catechins on gelatinase activities were examined; the most potent inhibitor of metalloproteinase activities was found to be EGCG. These results have indicated that green tea polyphenols including EGCG are useful for regulating metalloproteinase activities of fish meat.
Subject(s)
Catechin/analogs & derivatives , Enzyme Inhibitors/pharmacology , Flavonoids , Metalloendopeptidases/antagonists & inhibitors , Oncorhynchus mykiss , Phenols/pharmacology , Polymers/pharmacology , Tea/chemistry , Animals , Catechin/isolation & purification , Catechin/pharmacology , Chromatography, High Pressure Liquid , Edetic Acid/pharmacology , Gelatinases/antagonists & inhibitors , Gelatinases/blood , Gelatinases/metabolism , Metalloendopeptidases/blood , Metalloendopeptidases/metabolism , Muscle, Skeletal/enzymology , Oncorhynchus mykiss/blood , Oncorhynchus mykiss/metabolism , Skin/enzymologyABSTRACT
We have recently shown that green tea polyphenols, and especially (-)-epigallocatechin 3-gallate (EGCg), acted as potent inhibitors of matrix metalloproteinase activities as well as of proMMP-2 activation (M. Demeule, M. Brossard, M. Page, D. Gingras, R. Beliveau, Biochim. Biophys. Acta 1478 (2000)). In the present work, we sought to examine the involvement of MT1-MMP in the EGCg-induced inhibition of proMMP-2 activation. The incubation of U-87 glioblastoma cells in the presence of concanavalin A or cytochalasin D, two potent activators of MT1-MMP, resulted in proMMP-2 activation that was correlated with the cell surface proteolytic processing of MT1-MMP to its inactive 43 kDa form. Addition of EGCg strongly inhibited the MT1-MMP-dependent proMMP-2 activation. The inhibitory effect of EGCg on MT1-MMP was also demonstrated by the down-regulation of MT1-MMP transcript levels and by the inhibition of MT1-MMP-driven cell migration of transfected COS-7 cells. These observations suggest that this catechin may act at both the MT1-MMP gene and protein expression levels. In addition, treatment of cells with non-cytotoxic doses of EGCg significantly reduced the amount of secreted proMMP-2, and led to a concomitant increase in intracellular levels of that protein. This effect was similar to that observed using well-characterized secretion inhibitors such as brefeldin A and manumycin, suggesting that EGCg could also potentially act on intracellular secretory pathways. Taken together, these results indicate that EGCg targets multiple MMP-mediated cellular events in cancer cells and provides a new mechanism for the anticancer properties of that molecule.
Subject(s)
Camellia sinensis , Catechin/pharmacology , Flavonoids , Matrix Metalloproteinase Inhibitors , Metalloendopeptidases/antagonists & inhibitors , Phenols/pharmacology , Polymers/pharmacology , Animals , Antineoplastic Agents/pharmacology , COS Cells , Catechin/analogs & derivatives , Catechin/isolation & purification , Cell Movement/drug effects , Culture Media, Conditioned , Enzyme Inhibitors/pharmacology , Enzyme Precursors/antagonists & inhibitors , Gelatin/metabolism , Gelatinases/antagonists & inhibitors , Glioblastoma , Humans , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinases, Membrane-Associated , Metalloendopeptidases/genetics , Phenols/isolation & purification , Polymers/isolation & purification , Transcription, Genetic/drug effects , Transfection , Tumor Cells, Cultured/drug effectsABSTRACT
Flavanol (-)epigallocatechin-3-gallate is shown to be a potent natural inhibitor of leukocyte elastase that may be used to reduce elastase-mediated progression to emphysema and tumor invasion. This phyto-factor, abundant in green tea, exerts a dose-dependent, noncompetitive inhibition of leukocyte elastase at a noncytotoxic concentration and is effective in neutrophil culture. This inhibition shows an IC(50) of 0.4 microM, 30 times higher than the alpha1-protease inhibitor but lower than other known natural and synthetic elastase inhibitors. The flavanol inhibits leukocyte elastase at concentrations of 50, 150, and 2500 times lower than that effective on gelatinases (MMP-2 and MMP-9), thrombin, and cathepsin G, respectively, and also blocks elastase-mediated activation of MMP-9.
Subject(s)
Catechin/analogs & derivatives , Catechin/pharmacology , Enzyme Inhibitors/pharmacology , Leukocyte Elastase/antagonists & inhibitors , Neutrophils/enzymology , Catechin/therapeutic use , Cathepsin G , Cathepsins/antagonists & inhibitors , Cells, Cultured , Dose-Response Relationship, Drug , Emphysema/drug therapy , Enzyme Activation/drug effects , Enzyme Inhibitors/therapeutic use , Gelatinases/antagonists & inhibitors , Humans , Inflammation/drug therapy , Phytotherapy , Serine Endopeptidases , Thrombin/antagonists & inhibitorsABSTRACT
Using expression cloning to screen a human fetal kidney cDNA library for regulator(s) of pro-matrix metalloproteinase (MMP)-2 processing mediated by membrane-type (MT) 1 MMP, we isolated a cDNA whose product interfered with pro-MMP-2 activation. It encodes the NH(2)-terminal 313-amino acid region of a calcium-binding proteoglycan, testican 3, with a 3-amino acid substitution at the COOH terminus and thus was named N-Tes. N-Tes comprises a signal peptide, a unique domain, a follistatin-like domain, and a Ca(2+)-binding domain but lacks a COOH-terminal thyroglobulin domain and two putative glycosaminoglycan attachment sites of testican 3. Pro-MMP-2 activation by MT3-MMP was also inhibited by the coexpression of N-Tes. Immunoprecipitation analysis demonstrated direct interaction of N-Tes with either MT1-MMP or MT3-MMP. Expression of testican 1 or testican 3 but not testican 2 also inhibited pro-MMP-2 activation by either MT1-MMP or MT3-MMP. Deletion and substitution of amino acids residues in N-Tes revealed that the unique NH(2)-terminal domain of N-Tes is responsible for the inhibition of pro-MMP-2 activation by MT-MMPs. Expression of N-Tes and testican 3 was detected in normal brain but down-regulated in glioma tissues. Transfection of either the N-Tes or testican 3 gene into U251 glioma cells or Madin-Darby canine kidney cells transformed by erbB2 suppressed their invasive growth in collagen gel. These results suggest that both N-Tes and testican 3 would interfere with tumor invasion by inhibiting MT-MMPs.
Subject(s)
Enzyme Precursors/antagonists & inhibitors , Gelatinases/antagonists & inhibitors , Metalloendopeptidases/antagonists & inhibitors , Proteoglycans/physiology , Alternative Splicing , Amino Acid Sequence , Animals , Cloning, Molecular , DNA, Complementary/genetics , Dogs , Down-Regulation , Enzyme Activation , Enzyme Precursors/metabolism , Gelatinases/metabolism , Gene Library , Glioma/enzymology , Glioma/genetics , Glioma/pathology , Humans , Kidney/cytology , Kidney/physiology , Matrix Metalloproteinase 16 , Matrix Metalloproteinases, Membrane-Associated , Metalloendopeptidases/metabolism , Molecular Sequence Data , Peptide Mapping , Protein Isoforms , Protein Sorting Signals/genetics , Protein Structure, Tertiary , Proteoglycans/biosynthesis , Proteoglycans/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Transfection , Tumor Cells, CulturedABSTRACT
We have investigated the effects of different biologically active components from natural products, including green tea polyphenols (GTP), resveratrol, genistein and organosulfur compounds from garlic, on matrix metalloproteinase (MMP)-2, MMP-9 and MMP-12 activities. GTP caused the strongest inhibition of the three enzymes, as measured by fluorescence assays using gelatin or elastin as substrates. The inhibition of MMP-2 and MMP-9 caused by GTP was confirmed by gelatin zymography and was observed for MMPs associated with both various rat tissues and human brain tumors (glioblastoma and pituitary tumors). The activities of MMPs were also measured in the presence of various catechins isolated from green tea including (-)-epigallocatechin gallate (EGCG), (-)-epicatechin gallate(ECG), (-)-epigallocatechin (EGC), (-)-epicatechin (EC) and (+)-catechin (C). The most potent inhibitors of these activities, as measured by fluorescence and by gelatin or casein zymography, were EGCG and ECG. GTP and the different catechins had no effect on pancreatic elastase, suggesting that the effects of these molecules on MMP activities are specific. Furthermore, in vitro activation of proMMP-2 secreted from the glioblastomas cell line U-87 by the lectin concanavalin A was completely inhibited by GTP and specifically by EGCG. These results indicate that catechins from green tea inhibit MMP activities and proMMP-2 activation.